Steven Katz, MD
Ophthalmology · Columbus, OHNPI 1518906866
Payments from drug & device makers
Across 1,116 payments — averaging $229.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$202K
- AbbVie$42K
- Argenx US, Inc.$5K
- Teva Pharmaceuticals USA, Inc.$1K
- AstraZeneca$888
- Pfizer$720
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 273 | $202,411 |
| AbbVie(2 entities) | 339 | $41,942 |
| Argenx US, Inc. | 46 | $5,142 |
| Teva Pharmaceuticals USA, Inc. | 118 | $1,292 |
| AstraZeneca | 41 | $888 |
| Pfizer | 49 | $720 |
| Supernus Pharmaceuticals, Inc. | 50 | $526 |
| Genentech USA, Inc. | 35 | $504 |
| Mallinckrodt Hospital Products Inc. | 18 | $418 |
| Sun Pharmaceutical Industries Inc. | 25 | $378 |
| Biohaven Pharmaceutical Holding Company Ltd. | 30 | $323 |
| Biohaven Pharmaceuticals, Inc. | 22 | $237 |
| ANI Pharmaceuticals, Inc. | 8 | $177 |
| Lundbeck LLC | 9 | $155 |
| Axsome Therapeutics, Inc. | 8 | $138 |
| Oyster Point Pharma, Inc. | 7 | $134 |
| Johnson & Johnson | 2 | $122 |
| Bausch & Lomb Americas Inc. | 6 | $105 |
| Harrow Eye, LLC | 4 | $101 |
| Alcon | 4 | $100 |
| Impel Pharmaceuticals Inc. | 6 | $95 |
| Novartis | 4 | $69 |
| Merz Pharmaceuticals, LLC | 3 | $56 |
| Kala Pharmaceuticals, Inc. | 2 | $43 |
| Impel Pharmaceuticals LLC | 2 | $42 |
| Springworks Therapeutics, Inc. | 2 | $35 |
| Catalyst Pharmaceuticals, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Thea Pharma Inc. | 1 | $15 |
How this compares
$256,210 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Columbus
- David RogersColumbus$1.5M
- Alice EpitropoulosColumbus$702K
- David LehmannColumbus$58K
- Lisa BorkowskiColumbus$25K
- John PajkaLima$17.7M
- Justis EhlersCleveland$5M
- Lawrence SingermanBeachwood$3.9M
- Sunil SrivastavaCleveland$2.8M
- Daniel MillerCincinnati$2.3M
- Jonathan LassCleveland$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.